154 related articles for article (PubMed ID: 9664955)
1. Morphological findings in non-episode biopsies of kidney transplant allografts treated with FK506 or cyclosporine.
Kyo M; Hatori M; Takahara S; Kyakuno M; Nakamura T; Okada M; Kokado Y; Toki K; Ding XQ; Miki T; Miyamoto M; Okuyama A
Transpl Int; 1998; 11 Suppl 1():S100-3. PubMed ID: 9664955
[TBL] [Abstract][Full Text] [Related]
2. Clinical and histopathologic examination of renal allografts treated with tacrolimus (FK506) for at least one year.
Hatori M; Takahara S; Kyo M; Kokado Y; Nagano S; Okuyama A
Int J Urol; 1998 Nov; 5(6):526-33. PubMed ID: 9855119
[TBL] [Abstract][Full Text] [Related]
3. Arteriolopathy in non-episode biopsies of renal transplant allograft.
Toki K; Kyo M; Takahara S; Morozumi K; Ichimaru N; Tanaka T; Wang JD; Permpongkosol S; Oka K; Imai E; Miyamoto M; Kyakuno M; Nakamura T; Kojima Y; Kokado Y; Okuyama A
Clin Transplant; 2000; 14 Suppl 3():21-4. PubMed ID: 11092348
[TBL] [Abstract][Full Text] [Related]
4. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.
Haas M; Meehan SM; Josephson MA; Wit EJ; Woodle ES; Thistlethwaite JR
Am J Kidney Dis; 1999 Jul; 34(1):69-84. PubMed ID: 10401019
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group.
Solez K; Vincenti F; Filo RS
Transplantation; 1998 Dec; 66(12):1736-40. PubMed ID: 9884269
[TBL] [Abstract][Full Text] [Related]
6. [A case of subclinical IgA nephropathy and cyclosporin associated arteriolopathy diagnosed by non-episode biopsy of graft kidney after renal transplantation].
Namba Y; Kyakuno M; Nakamura T; Yamashiro H; Okada M; Toki K; Ichimaru N; Kokado Y; Takahara S; Okuyama A; Oka K; Imai E; Kyo M
Hinyokika Kiyo; 1999 May; 45(5):349-53. PubMed ID: 10410319
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
Nankivell BJ; PʼNg CH; OʼConnell PJ; Chapman JR
Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
[TBL] [Abstract][Full Text] [Related]
8. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
9. Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts.
Liptak P; Ivanyi B
Nat Clin Pract Nephrol; 2006 Jul; 2(7):398-404; quiz following 404. PubMed ID: 16932468
[TBL] [Abstract][Full Text] [Related]
10. Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts.
Morozumi K; Thiel G; Albert FW; Banfi G; Gudat F; Mihatsch MJ
Clin Nephrol; 1992 Jul; 38(1):1-8. PubMed ID: 1499163
[TBL] [Abstract][Full Text] [Related]
11. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G
Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of morphological characteristics of renal injuries of tacrolimus (FK506) and cyclosporin (CyA) in renal allografts: are the morphologic characteristics of FK506 and CyA nephrotoxicity similar?
Morozumi K; Sugito K; Oda A; Takeuchi O; Fukuda M; Usami T; Oikawa T; Fujinami T; Koyama K; Takeda A; Yoshida A; Haba T; Tominaga Y; Uchida K; Yokoyama I; Takagi H
Transplant Proc; 1996 Apr; 28(2):1076-8. PubMed ID: 8623232
[No Abstract] [Full Text] [Related]
13. Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.
Koziolek MJ; Riess R; Geiger H; Thévenod F; Hauser IA
Kidney Int; 2001 Jul; 60(1):156-66. PubMed ID: 11422747
[TBL] [Abstract][Full Text] [Related]
14. [Histologic findings in protocol biopsies of transplanted kidneys].
Tichý T; Tichý M; Zadrazil J; Krejcí K; Horcicka V; al-Jabry S; Bachleda P; Král V; Dusek J
Cesk Patol; 2003 Jan; 39(1):11-6. PubMed ID: 12673937
[TBL] [Abstract][Full Text] [Related]
15. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
Nielsen FT; Ottosen P; Starklint H; Dieperink H
Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
[TBL] [Abstract][Full Text] [Related]
16. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity.
Khanna A; Plummer M; Bromberek C; Bresnahan B; Hariharan S
Kidney Int; 2002 Dec; 62(6):2257-63. PubMed ID: 12427154
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine-associated thrombotic microangiopathy in renal allografts.
Zarifian A; Meleg-Smith S; O'donovan R; Tesi RJ; Batuman V
Kidney Int; 1999 Jun; 55(6):2457-66. PubMed ID: 10354295
[TBL] [Abstract][Full Text] [Related]
18. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
Yagisawa T; Omoto K; Shimizu T; Ishida H; Tanabe K
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():51-7. PubMed ID: 26031587
[TBL] [Abstract][Full Text] [Related]
19. Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsies.
Abrass CK; Berfield AK; Stehman-Breen C; Alpers CE; Davis CL
Am J Kidney Dis; 1999 Jan; 33(1):11-20. PubMed ID: 9915262
[TBL] [Abstract][Full Text] [Related]
20. Is kidney graft biopsy indicated in recipients with newly developed, microscopic hematuria?
Kim YS; Jeong HJ; Kim MS; Kim SI; Han DS; Park K
Clin Transplant; 1998 Apr; 12(2):104-8. PubMed ID: 9575397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
